Pharmacokinetics of bendroflumethiazide

Clin Pharmacol Ther. 1977 Oct;22(4):385-8. doi: 10.1002/cpt1977224385.

Abstract

Bendroflumethiazide (bft), 10 mg, was administered orally to 9 healthy volunteers. The concentrations of the diuretic in plasma and urine were determined by gas-liquid chromatography (GLC). Peak plasma levels (86 +/- 18 ng/ml) of bft were reached at 2 +/- 0.4 hr. The concentration declined with a mean t1/2 of 3.0 hr. The apparent volume of distribution averaged 1.48 L/kg. The major part of the drug was eliminated via nonrenal mechanisms, the nonrenal clearance being estimated to 269 +/- 77 ml/min and renal clearance to 105 +/- 24 ml/min. Urinary recovery of the thiazide averaged 30%.

MeSH terms

  • Adolescent
  • Adult
  • Bendroflumethiazide / metabolism*
  • Bendroflumethiazide / pharmacology
  • Calcium / urine
  • Chromatography, Gas
  • Diuresis / drug effects
  • Female
  • Humans
  • Kinetics
  • Magnesium / urine
  • Male
  • Natriuresis / drug effects
  • Potassium / urine
  • Time Factors

Substances

  • Bendroflumethiazide
  • Magnesium
  • Potassium
  • Calcium